GoodCap is a startup based in Canada.
GoodCap Pharmaceuticals develops novel drug candidates targeting neuroinflammatory diseases, focusing on treating PTSD and other psychiatric and neurodegenerative disorders through proprietary molecular combinations.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.